| proteoglycan metabolic process | GO:0006029 | 38 | 0.843 | |
| cell adhesion | GO:0007155 | 329 | 0.831 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.783 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.735 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.647 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.592 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.567 | |
| extracellular structure organization | GO:0043062 | 148 | 0.514 | |
| response to growth factor | GO:0070848 | 198 | 0.434 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.432 | |
| regulation of cell migration | GO:0030334 | 219 | 0.428 | |
| regulation of tooth mineralization | GO:0070170 | 2 | 0.398 | |
| negative regulation of tooth mineralization | GO:0070171 | 1 | 0.358 | |
| telencephalon development | GO:0021537 | 186 | 0.349 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.338 | |
| negative regulation of cell adhesion | GO:0007162 | 45 | 0.313 | |
| negative regulation of vasculature development | GO:1901343 | 26 | 0.300 | |
| pallium development | GO:0021543 | 120 | 0.282 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.274 | |
| negative regulation of blood vessel morphogenesis | GO:2000181 | 25 | 0.266 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.255 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.251 | |
| negative regulation of cell substrate adhesion | GO:0010812 | 16 | 0.247 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.245 | |
| forebrain development | GO:0030900 | 302 | 0.241 | |
| heart morphogenesis | GO:0003007 | 178 | 0.240 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.236 | |
| mineralocorticoid biosynthetic process | GO:0006705 | 1 | 0.232 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.219 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.216 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.207 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.204 | |
| response to amino acid | GO:0043200 | 37 | 0.200 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.200 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.192 | |
| skeletal system development | GO:0001501 | 356 | 0.191 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.190 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.187 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.180 | |
| cartilage condensation | GO:0001502 | 18 | 0.176 | |
| sensory perception | GO:0007600 | 245 | 0.168 | |
| aminoglycan metabolic process | GO:0006022 | 34 | 0.166 | |
| cerebral cortex development | GO:0021987 | 86 | 0.162 | |
| limb development | GO:0060173 | 166 | 0.144 | |
| connective tissue development | GO:0061448 | 179 | 0.138 | |
| angiogenesis | GO:0001525 | 201 | 0.133 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.132 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.131 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.130 | |
| regulation of cell motility | GO:2000145 | 236 | 0.126 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.124 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.123 | |
| cellular response to amino acid stimulus | GO:0071230 | 29 | 0.120 | |
| peptide cross linking | GO:0018149 | 10 | 0.112 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.111 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.108 | |
| sensory perception of sound | GO:0007605 | 97 | 0.107 | |
| limb bud formation | GO:0060174 | 10 | 0.106 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.103 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.102 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.102 | |
| gastrulation | GO:0007369 | 116 | 0.101 | |
| digestive tract development | GO:0048565 | 190 | 0.097 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.096 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.094 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.094 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.093 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.093 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.089 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.088 | |
| regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001239 | 26 | 0.088 | |
| tissue homeostasis | GO:0001894 | 115 | 0.085 | |
| protein heterooligomerization | GO:0051291 | 14 | 0.085 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.084 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.084 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.082 | |
| trabecula formation | GO:0060343 | 24 | 0.082 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.082 | |
| ear morphogenesis | GO:0042471 | 118 | 0.081 | |
| extracellular fibril organization | GO:0043206 | 2 | 0.080 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.079 | |
| response to acid chemical | GO:0001101 | 111 | 0.078 | |
| positive regulation of cell substrate adhesion | GO:0010811 | 47 | 0.078 | |
| fibril organization | GO:0097435 | 2 | 0.078 | |
| cardiac chamber development | GO:0003205 | 108 | 0.077 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.076 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.075 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.075 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.073 | |
| negative regulation of signal transduction in absence of ligand | GO:1901099 | 16 | 0.070 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.068 | |
| ear development | GO:0043583 | 200 | 0.068 | |
| aorta morphogenesis | GO:0035909 | 22 | 0.067 | |
| blood circulation | GO:0008015 | 195 | 0.066 | |
| negative regulation of angiogenesis | GO:0016525 | 25 | 0.066 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.065 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.065 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.064 | |
| negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001240 | 16 | 0.064 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.063 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.063 | |
| chondroitin sulfate metabolic process | GO:0030204 | 17 | 0.062 | |
| bone trabecula formation | GO:0060346 | 9 | 0.062 | |
| response to radiation | GO:0009314 | 165 | 0.062 | |
| bone trabecula morphogenesis | GO:0061430 | 12 | 0.061 | |
| renal system development | GO:0072001 | 225 | 0.060 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.060 | |
| artery development | GO:0060840 | 53 | 0.059 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.059 | |
| cartilage development involved in endochondral bone morphogenesis | GO:0060351 | 24 | 0.058 | |
| neuron migration | GO:0001764 | 122 | 0.058 | |
| hair cycle | GO:0042633 | 90 | 0.057 | |
| aorta smooth muscle tissue morphogenesis | GO:0060414 | 2 | 0.057 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.057 | |
| protein oligomerization | GO:0051259 | 67 | 0.057 | |
| muscle tissue development | GO:0060537 | 308 | 0.057 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.056 | |
| chondrocyte development | GO:0002063 | 24 | 0.056 | |
| bone development | GO:0060348 | 120 | 0.056 | |
| chondroitin sulfate proteoglycan metabolic process | GO:0050654 | 20 | 0.056 | |
| wound healing | GO:0042060 | 157 | 0.055 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.054 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.053 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.053 | |
| skin development | GO:0043588 | 220 | 0.053 | |
| retinal blood vessel morphogenesis | GO:0061304 | 3 | 0.051 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.051 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.051 | |
| head morphogenesis | GO:0060323 | 34 | 0.049 | |
| glycosaminoglycan metabolic process | GO:0030203 | 34 | 0.048 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.048 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.048 | |
| positive regulation of ras protein signal transduction | GO:0046579 | 13 | 0.047 | |
| regulation of extent of cell growth | GO:0061387 | 52 | 0.047 | |
| neuromuscular process | GO:0050905 | 99 | 0.047 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.047 | |
| circulatory system process | GO:0003013 | 197 | 0.046 | |
| jnk cascade | GO:0007254 | 72 | 0.046 | |
| regulation of neuron migration | GO:2001222 | 22 | 0.046 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.045 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.044 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.044 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.044 | |
| negative regulation of odontogenesis | GO:0042483 | 3 | 0.043 | |
| negative regulation of phospholipase activity | GO:0010519 | 4 | 0.042 | |
| peptide cross linking via chondroitin 4 sulfate glycosaminoglycan | GO:0019800 | 8 | 0.042 | |
| nephron development | GO:0072006 | 109 | 0.042 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.042 | |
| response to peptide hormone | GO:0043434 | 127 | 0.042 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.041 | |
| digestive system development | GO:0055123 | 200 | 0.040 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.040 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.039 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.039 | |
| palate development | GO:0060021 | 76 | 0.039 | |
| protein trimerization | GO:0070206 | 13 | 0.038 | |
| regulation of macrophage migration inhibitory factor signaling pathway | GO:2000446 | 1 | 0.038 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.038 | |
| notochord development | GO:0030903 | 20 | 0.038 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.038 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.038 | |
| substrate adhesion dependent cell spreading | GO:0034446 | 30 | 0.037 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 32 | 0.037 | |
| oxidation reduction process | GO:0055114 | 342 | 0.037 | |
| trabecula morphogenesis | GO:0061383 | 40 | 0.036 | |
| clathrin coat assembly | GO:0048268 | 2 | 0.036 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.035 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.035 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.035 | |
| cartilage development | GO:0051216 | 140 | 0.035 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.034 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.034 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.033 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.032 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.032 | |
| protein processing | GO:0016485 | 163 | 0.032 | |
| regulation of protein binding | GO:0043393 | 60 | 0.032 | |
| endomembrane system organization | GO:0010256 | 147 | 0.031 | |
| cell aggregation | GO:0098743 | 18 | 0.031 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.031 | |
| mucopolysaccharide metabolic process | GO:1903510 | 25 | 0.031 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.031 | |
| forebrain cell migration | GO:0021885 | 58 | 0.031 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.030 | |
| response to monosaccharide | GO:0034284 | 67 | 0.030 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.030 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.030 | |
| lipid localization | GO:0010876 | 126 | 0.030 | |
| aorta development | GO:0035904 | 23 | 0.029 | |
| camera type eye development | GO:0043010 | 266 | 0.029 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.029 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.029 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.028 | |
| endoderm formation | GO:0001706 | 20 | 0.028 | |
| appendage development | GO:0048736 | 166 | 0.028 | |
| tooth mineralization | GO:0034505 | 9 | 0.028 | |
| response to catecholamine | GO:0071869 | 4 | 0.028 | |
| regionalization | GO:0003002 | 337 | 0.028 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.028 | |
| protein heterotrimerization | GO:0070208 | 8 | 0.028 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.027 | |
| hair follicle morphogenesis | GO:0031069 | 29 | 0.027 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.027 | |
| epithelium migration | GO:0090132 | 63 | 0.027 | |
| fat cell differentiation | GO:0045444 | 160 | 0.027 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.026 | |
| innate immune response | GO:0045087 | 157 | 0.026 | |
| kidney development | GO:0001822 | 213 | 0.026 | |
| amine metabolic process | GO:0009308 | 45 | 0.026 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.026 | |
| negative regulation of protein activation cascade | GO:2000258 | 3 | 0.026 | |
| glucose homeostasis | GO:0042593 | 128 | 0.026 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.026 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.025 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.025 | |
| nuclear transport | GO:0051169 | 139 | 0.025 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.025 | |
| heart process | GO:0003015 | 94 | 0.025 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.025 | |
| face morphogenesis | GO:0060325 | 29 | 0.024 | |
| plasma membrane organization | GO:0007009 | 90 | 0.024 | |
| response to nutrient levels | GO:0031667 | 109 | 0.024 | |
| physiological cardiac muscle hypertrophy | GO:0003301 | 3 | 0.024 | |
| regulation of cell growth involved in cardiac muscle cell development | GO:0061050 | 3 | 0.024 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.024 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.024 | |
| myeloid leukocyte migration | GO:0097529 | 57 | 0.023 | |
| positive regulation of endothelial cell migration | GO:0010595 | 12 | 0.023 | |
| response to inorganic substance | GO:0010035 | 96 | 0.023 | |
| lipid homeostasis | GO:0055088 | 63 | 0.023 | |
| positive regulation of rho protein signal transduction | GO:0035025 | 7 | 0.023 | |
| odontogenesis | GO:0042476 | 78 | 0.023 | |
| smooth muscle tissue development | GO:0048745 | 22 | 0.023 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.023 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.023 | |
| cellular homeostasis | GO:0019725 | 240 | 0.023 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.023 | |
| ossification | GO:0001503 | 216 | 0.022 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.022 | |
| regulation of cell size | GO:0008361 | 72 | 0.022 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.022 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.022 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.022 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.021 | |
| regulation of system process | GO:0044057 | 200 | 0.021 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.021 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.021 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.021 | |
| glucan metabolic process | GO:0044042 | 32 | 0.021 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.021 | |
| mapk cascade | GO:0000165 | 281 | 0.021 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.021 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.021 | |
| hair follicle development | GO:0001942 | 85 | 0.020 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.020 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.020 | |
| developmental cell growth | GO:0048588 | 84 | 0.020 | |
| negative regulation of neuron migration | GO:2001223 | 6 | 0.020 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 38 | 0.020 | |
| regulation of epithelial cell migration | GO:0010632 | 35 | 0.020 | |
| integrin mediated signaling pathway | GO:0007229 | 27 | 0.020 | |
| calcium ion transport | GO:0006816 | 159 | 0.020 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.020 | |
| regulation of lipid transport | GO:0032368 | 36 | 0.020 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.020 | |
| telencephalon cell migration | GO:0022029 | 55 | 0.020 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.019 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.019 | |
| vesicle organization | GO:0016050 | 60 | 0.019 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.019 | |
| respiratory tube development | GO:0030323 | 167 | 0.019 | |
| protein localization to plasma membrane | GO:0072659 | 57 | 0.019 | |
| regulation of endodermal cell differentiation | GO:1903224 | 2 | 0.019 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.018 | |
| protein maturation | GO:0051604 | 176 | 0.018 | |
| response to peptide | GO:1901652 | 136 | 0.018 | |
| negative regulation of protein localization to plasma membrane | GO:1903077 | 5 | 0.018 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.018 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.018 | |
| replacement ossification | GO:0036075 | 26 | 0.018 | |
| membrane organization | GO:0061024 | 245 | 0.018 | |
| tissue remodeling | GO:0048771 | 102 | 0.018 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.018 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.017 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.017 | |
| regulation of binding | GO:0051098 | 111 | 0.017 | |
| immune effector process | GO:0002252 | 321 | 0.017 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.017 | |
| muscle system process | GO:0003012 | 141 | 0.017 | |
| regulation of cytokine secretion involved in immune response | GO:0002739 | 4 | 0.017 | |
| response to alcohol | GO:0097305 | 48 | 0.017 | |
| maintenance of location | GO:0051235 | 89 | 0.017 | |
| negative regulation of complement activation | GO:0045916 | 3 | 0.017 | |
| heart contraction | GO:0060047 | 93 | 0.016 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.016 | |
| collagen fibril organization | GO:0030199 | 32 | 0.016 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.016 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.016 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.016 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.016 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.016 | |
| cellular response to lipid | GO:0071396 | 145 | 0.016 | |
| cell growth involved in cardiac muscle cell development | GO:0061049 | 3 | 0.016 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.016 | Zebrafish |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.016 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.016 | |
| endocytosis | GO:0006897 | 168 | 0.016 | |
| protein targeting | GO:0006605 | 143 | 0.016 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.016 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.016 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.016 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.015 | |
| neurotransmitter catabolic process | GO:0042135 | 3 | 0.015 | |
| response to epidermal growth factor | GO:0070849 | 4 | 0.015 | |
| regulation of protein transport | GO:0051223 | 163 | 0.015 | |
| hormone metabolic process | GO:0042445 | 86 | 0.015 | |
| positive regulation of growth | GO:0045927 | 104 | 0.015 | |
| nuclear import | GO:0051170 | 95 | 0.015 | |
| cellular response to vitamin | GO:0071295 | 2 | 0.015 | |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.015 | |
| regulation of cell growth | GO:0001558 | 91 | 0.015 | |
| regulation of odontogenesis | GO:0042481 | 18 | 0.015 | |
| limb morphogenesis | GO:0035108 | 149 | 0.015 | |
| synapse organization | GO:0050808 | 125 | 0.015 | |
| positive regulation of cell growth | GO:0030307 | 33 | 0.015 | |
| cardiac cell development | GO:0055006 | 41 | 0.014 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.014 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.014 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.014 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.014 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.014 | |
| negative regulation of endothelial cell proliferation | GO:0001937 | 8 | 0.014 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.014 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.014 | |
| notochord cell differentiation | GO:0060034 | 1 | 0.014 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.014 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.014 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.014 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.014 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.014 | |
| negative regulation of cell proliferation involved in contact inhibition | GO:0060244 | 3 | 0.014 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.014 | |
| cellular glucan metabolic process | GO:0006073 | 32 | 0.014 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.013 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.013 | |
| neuron death | GO:0070997 | 154 | 0.013 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.013 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.013 | |
| neuromuscular process controlling balance | GO:0050885 | 59 | 0.013 | |
| response to defense related host nitric oxide production | GO:0052565 | 2 | 0.013 | |
| protein import into nucleus | GO:0006606 | 95 | 0.013 | |
| synaptic transmission cholinergic | GO:0007271 | 7 | 0.013 | |
| positive regulation of cardiac muscle contraction | GO:0060452 | 2 | 0.013 | |
| cell adhesion mediated by integrin | GO:0033627 | 18 | 0.013 | |
| lung development | GO:0030324 | 164 | 0.013 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.013 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.012 | |
| endoderm development | GO:0007492 | 45 | 0.012 | |
| regulation of protein localization | GO:0032880 | 231 | 0.012 | |
| glycogen metabolic process | GO:0005977 | 32 | 0.012 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.012 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.012 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.012 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.012 | |
| regulation of jnk cascade | GO:0046328 | 62 | 0.012 | |
| granulocyte migration | GO:0097530 | 43 | 0.012 | |
| developmental maturation | GO:0021700 | 193 | 0.012 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.012 | |
| positive regulation of hormone metabolic process | GO:0032352 | 3 | 0.012 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.012 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.012 | |
| regulation of sphingolipid biosynthetic process | GO:0090153 | 1 | 0.012 | |
| molting cycle | GO:0042303 | 90 | 0.012 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.012 | |
| cytokine production | GO:0001816 | 319 | 0.012 | |
| protein catabolic process | GO:0030163 | 221 | 0.012 | |
| negative regulation of lipase activity | GO:0060192 | 7 | 0.012 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.012 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.012 | |
| physiological muscle hypertrophy | GO:0003298 | 3 | 0.012 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.012 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.012 | |
| negative regulation of camp mediated signaling | GO:0043951 | 3 | 0.012 | |
| regulation of biomineral tissue development | GO:0070167 | 33 | 0.012 | |
| cellularization | GO:0007349 | 1 | 0.012 | |
| positive regulation of camp mediated signaling | GO:0043950 | 3 | 0.011 | |
| respiratory system development | GO:0060541 | 190 | 0.011 | |
| negative regulation of embryonic development | GO:0045992 | 22 | 0.011 | |
| compound eye development | GO:0048749 | 1 | 0.011 | |
| regulation of ceramide biosynthetic process | GO:2000303 | 1 | 0.011 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.011 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.011 | |
| sensory system development | GO:0048880 | 3 | 0.011 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.011 | |
| response to thyroid hormone | GO:0097066 | 2 | 0.011 | |
| trunk segmentation | GO:0035290 | 4 | 0.011 | |
| response to starvation | GO:0042594 | 65 | 0.011 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.011 | |
| regulation of lipase activity | GO:0060191 | 15 | 0.011 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.011 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.011 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.011 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.011 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.011 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.011 | |
| organelle localization | GO:0051640 | 179 | 0.011 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.011 | |
| phagocytosis | GO:0006909 | 66 | 0.011 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.011 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.011 | |
| negative regulation of cell morphogenesis involved in differentiation | GO:0010771 | 48 | 0.011 | |
| endothelial cell migration | GO:0043542 | 44 | 0.011 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.011 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.011 | |
| endodermal cell differentiation | GO:0035987 | 14 | 0.011 | |
| hormone secretion | GO:0046879 | 128 | 0.011 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.011 | |
| response to endoplasmic reticulum stress | GO:0034976 | 53 | 0.011 | |
| otic vesicle development | GO:0071599 | 14 | 0.011 | |
| tissue migration | GO:0090130 | 68 | 0.011 | |
| single organism nuclear import | GO:1902593 | 95 | 0.010 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.010 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.010 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.010 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.010 | |
| placenta development | GO:0001890 | 140 | 0.010 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.010 | |
| cation transport | GO:0006812 | 399 | 0.010 | |
| mesenchyme development | GO:0060485 | 152 | 0.010 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.010 | |
| positive regulation of vesicle fusion | GO:0031340 | 2 | 0.010 | |
| dna metabolic process | GO:0006259 | 303 | 0.010 | |
| anion transport | GO:0006820 | 177 | 0.010 | |
| long chain fatty acid import | GO:0044539 | 2 | 0.010 | |
| cell growth | GO:0016049 | 130 | 0.010 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.010 | |
| trunk neural crest cell migration | GO:0036484 | 4 | 0.010 | |
| fibrinolysis | GO:0042730 | 3 | 0.010 | |
| skin morphogenesis | GO:0043589 | 38 | 0.010 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.010 | |
| positive regulation of peptidyl serine phosphorylation | GO:0033138 | 25 | 0.010 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.010 | |
| synaptic transmission | GO:0007268 | 329 | 0.010 | |
| otolith morphogenesis | GO:0032474 | 3 | 0.010 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.010 | |
